Biomedical Engineering Reference
In-Depth Information
49. David Vasily. Lasers Surg Med 2007.
50. Kroon MW, Wind BS, Beck JF, et al. Nonablative 1550-nm fractional laser
therapy versus triple topical therapy for the treatment of melasma: a
randomized controlled pilot study. J Am Acad Dermatol 2011; 64: 516-23.
51. Polder KD, Bruce S. Treatment of melasma using a novel 1,927 nm fractional
thulium fi ber laser: a pilot study. Dermatol Surg 2012; 38: 199-206.
52. Katz TM, Goldberg LH, Marquez D, et al. Nonablative fractional
photothermolysis for facial actinic keratoses: 6-month follow up with
histologic evaluation. J Am Acad Dermatol 2011; 65: 349-56.
53. Weiss ET, Anolik R, Brightman L, et al. Long term follow-up of 1927 nm
fractional resurfacing for actinic keratoses of the face. Lasers Surg Med
2011; 43: 926.
54. Friedman PM, Landau JM, Moody MN, et al. 1550 nm and 1927 nm
fractional laser resurfacing for the treatment of actinic keratosis and
Photodamage: A comparative study. Surg Med 2011; 43: 926.
55. Ghasri P, Admani S, Petelin A, et al. Treatment of actinic cheilitis using a
1927 nm thulium fractional laser. Dermatol Surg 2012; 38: 504-7.
56. Anolik R, Friedman PM, Weiss ET, et al. Non-ablative fractional
resurfacing with the 1927 nm thulium laser is an effective, well-tolerated
treatment for actinic cheilitis. Lasers Surg Med 2011; 43: 927.
57. Ruiz-Rodriguez R, Lopez L, Candelas D, et al. Enhanced effi cacy of
photodynamic therapy after fractional resurfacing: fractional photodynamic
rejuvenation. J Drugs Dermatol 2007; 6: 818-20.
